Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Sutter

Showing results (171-180 of 184) with videos related to

Pageof 19
Sort By:
Lancet (London, England)|September 22, 2015
Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trialRoland W Sutter, Sunil Bahl, Jagadish M Deshpande, et al.
Science (New York, N.Y.)|August 23, 2014
Polio eradication. Efficacy of inactivated poliovirus vaccine in IndiaHamid Jafari, Jagadish M Deshpande, Roland W Sutter, et al.
The Journal of Infectious Diseases|November 24, 2020
Randomized Controlled Clinical Trial of Bivalent Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine in Nigerian ChildrenBeckie N Tagbo, Harish Verma, Zubairu M Mahmud, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 23, 2006
Development and consideration of global policies for managing the future risks of poliovirus outbreaks: insights and lessons learned through modelingKimberly M Thompson, Radboud J Duintjer Tebbens, Mark A Pallansch, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|July 19, 2012
Expert review on poliovirus immunity and transmissionRadboud J Duintjer Tebbens, Mark A Pallansch, Konstantin M Chumakov, et al.
The Journal of Infectious Diseases|November 12, 2020
Immunogenicity of Reduced-Dose Monovalent Type 2 Oral Poliovirus Vaccine in Mocuba, MozambiqueNilsa de Deus, Igor Paulo Ubisse Capitine, Adilson Fernando Loforte Bauhofer, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|April 5, 2013
Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needsRadboud J Duintjer Tebbens, Mark A Pallansch, Konstantin M Chumakov, et al.
The Journal of Infectious Diseases|February 25, 2016
Role of Serial Polio Seroprevalence Studies in Guiding Implementation of the Polio Eradication Initiative in Kano, Nigeria: 2011-2014Kehinde TemilolaOluwa Craig, Harish Verma, Zubairu Iliyasu, et al.
The Lancet. Global Health|December 24, 2021
Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a campaign: a pragmatic, open-label, non-inferiority trial in The GambiaAdedapo O Bashorun, Mariama Badjie Hydara, Ikechukwu Adigweme, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 1998
Outbreak of paralytic poliomyelitis in Albania, 1996: high attack rate among adults and apparent interruption of transmission following nationwide mass vaccinationD R Prevots, M L Ciofi degli Atti, A Sallabanda, et al.
Pageof 19

Showing results (171-180 of 184) with videos related to

Sort By:
Pageof 19
Lancet (London, England)|September 22, 2015
Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trialRoland W Sutter, Sunil Bahl, Jagadish M Deshpande, et al.
Science (New York, N.Y.)|August 23, 2014
Polio eradication. Efficacy of inactivated poliovirus vaccine in IndiaHamid Jafari, Jagadish M Deshpande, Roland W Sutter, et al.
The Journal of Infectious Diseases|November 24, 2020
Randomized Controlled Clinical Trial of Bivalent Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine in Nigerian ChildrenBeckie N Tagbo, Harish Verma, Zubairu M Mahmud, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 23, 2006
Development and consideration of global policies for managing the future risks of poliovirus outbreaks: insights and lessons learned through modelingKimberly M Thompson, Radboud J Duintjer Tebbens, Mark A Pallansch, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|July 19, 2012
Expert review on poliovirus immunity and transmissionRadboud J Duintjer Tebbens, Mark A Pallansch, Konstantin M Chumakov, et al.
The Journal of Infectious Diseases|November 12, 2020
Immunogenicity of Reduced-Dose Monovalent Type 2 Oral Poliovirus Vaccine in Mocuba, MozambiqueNilsa de Deus, Igor Paulo Ubisse Capitine, Adilson Fernando Loforte Bauhofer, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|April 5, 2013
Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needsRadboud J Duintjer Tebbens, Mark A Pallansch, Konstantin M Chumakov, et al.
The Journal of Infectious Diseases|February 25, 2016
Role of Serial Polio Seroprevalence Studies in Guiding Implementation of the Polio Eradication Initiative in Kano, Nigeria: 2011-2014Kehinde TemilolaOluwa Craig, Harish Verma, Zubairu Iliyasu, et al.
The Lancet. Global Health|December 24, 2021
Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a campaign: a pragmatic, open-label, non-inferiority trial in The GambiaAdedapo O Bashorun, Mariama Badjie Hydara, Ikechukwu Adigweme, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 1998
Outbreak of paralytic poliomyelitis in Albania, 1996: high attack rate among adults and apparent interruption of transmission following nationwide mass vaccinationD R Prevots, M L Ciofi degli Atti, A Sallabanda, et al.
Pageof 19